Skip to main content
GRDN logo

GRDN · Guardian Pharmacy Services, Inc. · Analyst Estimates

Track GRDN — free
$40.78 +0.10 (+0.25%) At close · Sep 30
Market Cap
$2.61B
Shares
63.34M
Volume · Sep 30 540.21K Avg daily vol (3M) 477.5K

Analyst Estimates

Compare analyst forecasts for Guardian Pharmacy Services, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-24 07:34 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.25
1.30143
1.34
—
1.30333
1.26
1.30333
1.26
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
1435324000
1442482490
1450000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.36
1.43429
1.49
—
1.43
1.35833
1.43
1.35833
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
5
5
Revenue
USD
Publication date not stated
1496888950
1534112280
1600000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.29
0.31429
0.33
—
0.315
0.30167
0.315
0.30167
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
362807000
365758770
368663000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.39
0.41286
0.45
—
0.415
0.40833
0.415
0.40833
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
3
3
Revenue
USD
Publication date not stated
384153000
387778150
393000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —
Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 5 filings 5 filers Visit website Investor relations